Investor Insight InMed is a pharmaceutical drug development company advancing proprietary small-molecule drugs in Alzheimer’s and ophthalmology, backed by a…
The Indian rupee opened at an all-time low on December 3, slipping past the 90-per-dollar threshold as persistent foreign portfolio…